Another medium molecule hits the market
August 8, 2019Bremelanotide (commercialized as Vyleesi) has recently been approved by the FDA for the treatment of low sexual desire in women.
Read More
150 years of love
August 1, 20192019 is the International Year of the Periodic Table, an initiative by the IUPAC with support from the UNESCO.
Read More
2018 in Numbers
March 25, 2019As usual, the figures for started and completed projects are not very significant, but they are a 10% higher than in 2017, because 2018 was indeed one of the busiest years in GalChimia’s history.
Read More
How to crash your own presentation
March 1, 2018Would you crash your own presentation? We give you 10 techniques and other small tricks to follow to make an attractive presentation.
Read More
2017 in Numbers
January 15, 2018Another year, another set of figures for O Pino Site. 2017 in Numbers shows Galchimia’s figures about projects and products in the past year.
Read More
Pharma vs. Agro
June 3, 2016GalChimia customers come from several industries, but the majority can be classified into two categories: agrochemical and pharmaceutical. What are the…
Read More
2015 in Numbers
January 21, 2016Following our long standing tradition, we present here our figures about projects and products of 2015. Compiling this info takes only…
Read More
Are cancer Immunotherapy and small molecules compatible?
August 20, 2015Our immune system does a remarkable job of defending us against diseases. We can also consider that it has the greatest…
Read More
Is there a reason to refuse generics?
August 9, 2015“This generic is an exact copy of your formal medicine.” We have all heard this assurance from our pharmacists, but why…
Read More
When Vet becomes a strategic goal for Pharma
May 25, 2015The “One Health” approach emerged following the unprecedented global response to the highly pathogenic avian influenza in 2007, but the philosophy…
Read More